Xuan Ding

760 total citations
30 papers, 606 citations indexed

About

Xuan Ding is a scholar working on Molecular Biology, Electrical and Electronic Engineering and Pharmaceutical Science. According to data from OpenAlex, Xuan Ding has authored 30 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Electrical and Electronic Engineering and 5 papers in Pharmaceutical Science. Recurrent topics in Xuan Ding's work include Drug Solubulity and Delivery Systems (4 papers), Advanced battery technologies research (4 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Xuan Ding is often cited by papers focused on Drug Solubulity and Delivery Systems (4 papers), Advanced battery technologies research (4 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Xuan Ding collaborates with scholars based in China, United States and Canada. Xuan Ding's co-authors include Juliann G. Kiang, George C. Tsokos, Joseph R. Robinson, Uwe Ohler, Stoyan Georgiev, Alan P. Boyle, David E. McClain, Sayan Mukherjee, John P. Rose and J. Van Gelder and has published in prestigious journals such as Advanced Materials, ACS Nano and Energy & Environmental Science.

In The Last Decade

Xuan Ding

29 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuan Ding China	15	283	111	72	71	62	30	606
Ben Kent Germany	16	208 0.7×	76 0.7×	65 0.9×	147 2.1×	50 0.8×	26	657
Junichi Takano Japan	16	108 0.4×	197 1.8×	127 1.8×	84 1.2×	23 0.4×	42	642
Mei‐Jane Li Taiwan	18	280 1.0×	34 0.3×	83 1.2×	87 1.2×	179 2.9×	39	853
Akira Yagi Japan	14	221 0.8×	65 0.6×	170 2.4×	103 1.5×	41 0.7×	35	733
С. В. Казаков Russia	17	317 1.1×	35 0.3×	58 0.8×	142 2.0×	67 1.1×	74	829
Jean‐François Angiboust France	15	172 0.6×	31 0.3×	56 0.8×	162 2.3×	108 1.7×	33	802
John Hubble United Kingdom	15	221 0.8×	64 0.6×	50 0.7×	327 4.6×	89 1.4×	55	793
Zheng‐liang Zhi United Kingdom	16	331 1.2×	136 1.2×	102 1.4×	208 2.9×	40 0.6×	28	711
Stelios T. Tzannis United States	9	335 1.2×	26 0.2×	48 0.7×	86 1.2×	102 1.6×	9	648
Mirco Sorci United States	19	460 1.6×	80 0.7×	126 1.8×	198 2.8×	10 0.2×	40	854

Countries citing papers authored by Xuan Ding

Since Specialization

Citations

This map shows the geographic impact of Xuan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuan Ding more than expected).

Fields of papers citing papers by Xuan Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuan Ding. The network helps show where Xuan Ding may publish in the future.

Co-authorship network of co-authors of Xuan Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Xuan Ding. A scholar is included among the top collaborators of Xuan Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuan Ding. Xuan Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Yun, Xuan Ding, Yuan Zhuang, et al.. (2025). Application of Liposome Encapsulation Drug in Inhibiting Ferroptosis and Reducing Radiation Damage During Radiotherapy. Nano Biomedicine and Engineering. 17(4). 517–528. 1 indexed citations

Ding, Xuan, Shiwei Xu, Guofeng Wang, et al.. (2025). Lithium sieving with crown ethers covalently held by size-matched framework. Chemical Engineering Journal. 519. 164993–164993. 3 indexed citations

Wu, Jianyang, Mengchao Li, Xuan Ding, et al.. (2024). Upgrading Gel Electrolytes Through Electrostatic‐Induced Dual‐Salt Paradigm for Superior Zn‐Ion Battery Performance. Small. 20(38). e2400390–e2400390. 12 indexed citations

Li, Xilong, Kaiwen Qi, Xuan Ding, et al.. (2024). Ion-Anchored Strategy for MnO₂/Mn²⁺ Chemistry without “Dead Mn” and Corrosion. ACS Nano. 18(39). 27016–27025. 17 indexed citations

Qi, Kaiwen, Shiqiang Wei, Huaisheng Ao, et al.. (2024). Trade-off between H₂O-rich and H₂O-poor electric double layers enables highly reversible Zn anodes in aqueous Zn-ion batteries. Energy & Environmental Science. 17(7). 2566–2575. 67 indexed citations

Qi, Kaiwen, et al.. (2023). A mesoporous Al₂O₃ zincophilic sieve enables ultra-long lifespan of Zn-ion batteries. Chemical Communications. 59(54). 8448–8451.

Lu, Zhangwei, Yutong Liu, Yibing Deng, et al.. (2022). Oa AEP1-mediated PNA-protein conjugation enables erasable imaging of membrane proteins. Chemical Communications. 58(60). 8448–8451. 11 indexed citations

Ding, Xuan, et al.. (2020). Identification of potential microRNAs in glioblastoma using bioinformatic analysis and prognostic evaluation. Translational Cancer Research. 9(12). 7432–7439. 1 indexed citations

Ding, Xuan, Jeffrey S. Day, & David C. Sperry. (2016). Physiologically Based Absorption Modeling to Design Extended-Release Clinical Products for an Ester Prodrug. The AAPS Journal. 18(6). 1424–1438. 2 indexed citations

10.

Ding, Xuan, et al.. (2015). Assessment of In Vivo Clinical Product Performance of a Weak Basic Drug by Integration of In Vitro Dissolution Tests and Physiologically Based Absorption Modeling. The AAPS Journal. 17(6). 1395–1406. 17 indexed citations

11.

Ding, Xuan, et al.. (2015). Formaldehyde cross-linking and structural proteomics: Bridging the gap. Methods. 89. 91–98. 21 indexed citations

12.

Ding, Xuan, et al.. (2013). Investigation of Clinical Pharmacokinetic Variability of an Opioid Antagonist Through Physiologically Based Absorption Modeling. Journal of Pharmaceutical Sciences. 102(8). 2859–2874. 5 indexed citations

13.

Ding, Xuan, John P. Rose, & J. Van Gelder. (2012). Developability assessment of clinical drug products with maximum absorbable doses. International Journal of Pharmaceutics. 427(2). 260–269. 23 indexed citations

14.

Georgiev, Stoyan, et al.. (2010). Evidence-ranked motif identification. Genome biology. 11(2). R19–R19. 74 indexed citations

15.

Ding, Xuan, Ian T. Paulsen, Apurba K. Bhattacharjee, et al.. (2006). A high efficiency cloning and expression system for proteomic analysis. PROTEOMICS. 6(14). 4038–4046. 3 indexed citations

16.

Kiang, Juliann G., Phillip D. Bowman, Xinyue Lu, et al.. (2006). Geldanamycin prevents hemorrhage-induced ATP loss by overexpressing inducible HSP70 and activating pyruvate dehydrogenase. American Journal of Physiology-Gastrointestinal and Liver Physiology. 291(1). G117–G127. 22 indexed citations

17.

Ding, Xuan, Apurba K. Bhattacharjee, Mikeljon P. Nikolich, et al.. (2005). Cloning, expression, and purification of Brucella suis outer membrane proteins. Protein Expression and Purification. 40(1). 134–141. 6 indexed citations

18.

Ding, Xuan, Thomas C. Stringfellow, & Joseph R. Robinson. (2004). Self-association of cromolyn sodium in aqueous solution characterized by nuclear magnetic resonance spectroscopy. Journal of Pharmaceutical Sciences. 93(5). 1351–1358. 24 indexed citations

19.

Ding, Xuan, Parshuram Rath, Thomas Stringfellow, et al.. (2004). Oral Absorption Enhancement of Cromolyn Sodium Through Noncovalent Complexation. Pharmaceutical Research. 21(12). 2196–2206. 36 indexed citations

20.

Kiang, Juliann G., Xuan Ding, & David E. McClain. (1998). Overexpression of HSP-70 Attenuates Increases in [Ca2+]iand Protects Human Epidermoid A-431 Cells after Chemical Hypoxia. Toxicology and Applied Pharmacology. 149(2). 185–194. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact